Selective serotonin reuptake inhibitors and the risk of hepatocellular carcinoma in hepatitis B virus-infected patients

BACKGROUND: This study aimed to investigate the association between the use of selective serotonin reuptake inhibitors (SSRIs) and the risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B virus (HBV) infection. METHODS: We conducted a population-based cohort study by using cla...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Manag Res
Autors principals: Chang, Chia-Ming, Hsieh, Ming-Shun, Yang, Tsung-Chieh, Hsieh, Vivian Chia-Rong, Chiang, Jen-Huai, Huang, Hsien-Hao, How, Chorng-Kuang, Hu, Sung-Yuan, Yen, David Hung-Tsang
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2017
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5713708/
https://ncbi.nlm.nih.gov/pubmed/29238221
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S148097
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars